Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luuk Gras

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|April 28, 2022
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMTDonal P McLornan, Luuk Gras, Ivonne Martin, et al.
Haematologica|March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationLaurent Garderet, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTPatryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|May 15, 2023
Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literatureMarie Robin, Luuk Gras, Linda Koster, et al.
American Journal of Hematology|January 6, 2023
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationGuillermo Ortí, Luuk Gras, Nienke Zinger, et al.
Haematologica|December 22, 2022
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experienceDai Chihara, Luuk Gras, Nienke Zinger, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation|February 16, 2022
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMTJoanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, et al.
American Journal of Hematology|June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis RegistryJuan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|April 28, 2022
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMTDonal P McLornan, Luuk Gras, Ivonne Martin, et al.
Haematologica|March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationLaurent Garderet, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTPatryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|May 15, 2023
Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literatureMarie Robin, Luuk Gras, Linda Koster, et al.
American Journal of Hematology|January 6, 2023
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationGuillermo Ortí, Luuk Gras, Nienke Zinger, et al.
Haematologica|December 22, 2022
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experienceDai Chihara, Luuk Gras, Nienke Zinger, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation|February 16, 2022
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMTJoanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, et al.
American Journal of Hematology|June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis RegistryJuan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Pageof 8